Frontiers in psychology
January 1, 2023
Jaime Navarrete, Marta Fontana-Mcnally, Ariadna Colomer-Carbonell et al.
9 citations
The Spanish versions of the Toronto Mindfulness Scale (TMS) and the State Mindfulness Scale (SMS) show adequate reliability and validity for measuring state mindfulness, though the SMS specific factors have poor reliability when controlling for the general factor. Data from six non-clinical Spanish samples (TMS n=119, SMS n=223) were analyzed using confirmatory factor analysis. The best-fitting model for the TMS was a correlated two-factor structure (curiosity and decentering). For the SMS, a bifactor structure (general factor, mindfulness of body, and mindfulness of mind) fit best. Both scales detected changes in state mindfulness after meditation practices. The patterns of correlations with measures of trait mindfulness, decentering, non-attachment, depression, anxiety, stress, affect, self-criticism, and self-reassurance were mostly as expected.
Frontiers in pain research (Lausanne, Switzerland)
January 1, 2024
Sonia Medina, Owen O'Daly, Matthew A Howard et al.
5 citations
Mind-body treatments such as mindfulness-based stress reduction (MBSR) and a psychoeducational program (FibroQoL) reduced pain catastrophizing in patients with fibromyalgia syndrome (FMS). Using resting-state fMRI, the study found that MBSR specifically reduced functional connectivity within the sensorimotor network compared to a treatment-as-usual group. Baseline connectivity between the salience network and sensorimotor network predicted pain reduction differently for each treatment: negatively for MBSR and positively for FibroQoL, with large to very large effect sizes. Among MBSR patients with lower baseline connectivity, more mindfulness practice was linked to greater clinical improvement. These results suggest that different mind-body treatments engage distinct brain networks and that functional connectivity measures could serve as predictors of treatment response.
Frontiers in psychology
January 1, 2024
Tania Badia-Aguarón, Estíbaliz Royuela-Colomer, Vanessa Pera-Guardiola et al.
1 citation
A 5-month randomized controlled trial will test whether adding Mindfulness for Health, cognitive training using the NeuronUP® platform, or their combination to usual care improves outcomes for 120 children aged 7–12 with ADHD. The study will assess ADHD symptoms, executive functions, and comorbid symptoms before and after the interventions and at a 5-month follow-up. It will also explore whether mindfulness and emotional regulation mediate clinical outcomes and whether certain characteristics predict treatment response. This is the first test of the combined intervention and of cognitive training alone in this setting, aiming to lay groundwork for a larger definitive trial.